Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2025-12-25 @ 1:23 PM
NCT ID:
NCT02457559
Pre Assignment Details:
102 participants were screened. Participants must have been enrolled in parent study ONO-4059POE001 (NCT01659255) to be eligible to receive continued access to tirabrutinib in this rollover study. The dosing regimen was based on the prior dosing regimen from the parent study. As pre-specified in the protocol, the data from both the parent and rollover studies were analyzed together for participants in this rollover study.
Recruitment Details:
Participants were enrolled at study sites in the United Kingdom and France. The first participant was screened on 10 September 2015. The last study visit occurred on 30 December 2020.
Study:
NCT02457559
Study Brief:
Results Section:
NCT02457559